Phase 2 Meningococcal Infection Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
Immunogenicity and Safety of Meningococcal Conjugate Vaccine (EG-MCV4) in Healthy Adults Aged 19 to 55 Years Old
Meningococcal Infections
EyeGene Inc.1,123 enrolled1 locationNCT07204457
Recruiting
Phase 2
Azithromycin for Meningococcal Carriage
Meningococcal Infections
Emory University1,120 enrolled1 locationNCT06618534